Envarsus xr and Multimorbidity - a phase IV clinical study of FDA data

Summary:

Multimorbidity is reported as a side effect among people who take Envarsus xr (tacrolimus), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Gliclazide, and have Lower respiratory tract infection.

The phase IV clinical study analyzes which people have Multimorbidity when taking Envarsus xr. It is created by eHealthMe based on reports of 3,807 people who have side effects when taking Envarsus xr from the FDA, and is updated regularly.

What is Envarsus xr?

Envarsus xr has active ingredients of tacrolimus. eHealthMe is studying from 3,819 Envarsus xr users. Check the latest studies of Envarsus xr.

What is Multimorbidity?

Multimorbidity (co-occurrence of two or more chronic medical conditions in one person) is found to be associated with 91 drugs and 176 conditions by eHealthMe. Check the latest studies of Multimorbidity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

3,807 people reported to have side effects when taking Envarsus xr.
Among them, 50 people (1.31%) have Multimorbidity.

Among these 50 people:

How long have people been on Envarsus xr when they have Multimorbidity? *

What is the gender of people who have Multimorbidity when taking Envarsus xr? *

female: 0.0 %
male: 100 %

What is the age of people who have Multimorbidity when taking Envarsus xr? *

What are other drugs people take besides Envarsus xr? *

What are other side effects people have besides Multimorbidity? *

Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 50 people, 100.00%
Oesophageal Carcinoma (cancer tumour of oesophagus): 50 people, 100.00%
Cardiac Failure Congestive: 50 people, 100.00%
Coughing Up Blood: 50 people, 100.00%
Enlarged Heart: 50 people, 100.00%
Fever: 50 people, 100.00%
Hypoglycemia (low blood sugar): 50 people, 100.00%
Inflammatory Marker Increased: 50 people, 100.00%
Lower Respiratory Tract Infection: 50 people, 100.00%
Lung Consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces): 50 people, 100.00%

What are the existing conditions these people have? *

Lower Respiratory Tract Infection: 44 people, 88.00%
Pneumonia: 39 people, 78.00%
Gastric Ulcer (stomach ulcer): 37 people, 74.00%
Mediastinitis (inflammation of the tissues in the mid-chest): 35 people, 70.00%
Rashes (redness): 2 people, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Envarsus xr and have Multimorbidity?

- Check whether Multimorbidity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Envarsus xr:

Envarsus xr (3,819 reports)

Multimorbidity treatments and more:

Multimorbidity (1,305 reports)

Browse all side effects of Envarsus xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multimorbidity:

Multimorbidity (91 drugs)

Browse all the conditions that are associated with Multimorbidity:

Multimorbidity (176 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Envarsus xr) and Envarsus xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.